Recommendations for HER2 testing in the UK

Ian O. Ellis(University of Nottingham), P Barrett Lee(Whitchurch Hospital)

Journal of Clinical Pathology

December 1, 2000

10.1136/jcp.53.12.890

Cited by 142

Related Papers

The 2019 World Health Organization classification of tumours of the breast

|Histopathology|2020|1.1k

Clinical and genetic characteristics of hereditary pancreatitis in Europe

|Clinical Gastroenterology and Hepatology|2004|615

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

|Journal of Clinical Oncology|2008|464

Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial

|The Lancet Oncology|2020|234